[Rhabdomyolysis in cardiac transplant recipient due to verapamil interaction with simvastatin and cyclosporin treatment]

Therapie. 2003 Mar-Apr;58(2):168-70. doi: 10.2515/therapie:2003026.
[Article in French]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Calcium Channel Blockers / adverse effects*
  • Cyclosporine / adverse effects*
  • Drug Interactions
  • Heart Transplantation / physiology*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
  • Immunosuppressive Agents / adverse effects*
  • Male
  • Middle Aged
  • Rhabdomyolysis / chemically induced*
  • Rhabdomyolysis / physiopathology
  • Simvastatin / adverse effects*
  • Verapamil / adverse effects*

Substances

  • Calcium Channel Blockers
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Immunosuppressive Agents
  • Cyclosporine
  • Simvastatin
  • Verapamil